Atara Biotherapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2012 to Q3 2024.
  • Atara Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$21.8M, a 68.7% increase year-over-year.
  • Atara Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$131M, a 55% increase year-over-year.
  • Atara Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$276M, a 1.61% increase from 2022.
  • Atara Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$281M, a 17.6% increase from 2021.
  • Atara Biotherapeutics, Inc. annual Operating Income (Loss) for 2021 was -$340M, a 10.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$131M -$21.8M +$47.9M +68.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$179M -$18.2M +$53.2M +74.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$232M -$31.2M +$43.8M +58.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$276M -$60M +$15.6M +20.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$292M -$69.6M +$15M +17.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$307M -$71.4M -$39.3M -122% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$267M -$75M +$13.2M +15% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$281M -$75.5M +$17.9M +19.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$298M -$84.6M +$190K +0.22% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$299M -$32.1M +$51.9M +61.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$350M -$88.2M -$9.98M -12.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$340M -$93.4M -$11.7M -14.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-08
Q3 2021 -$329M -$84.8M -$10.1M -13.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$319M -$84M -$6.05M -7.76% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$313M -$78.2M -$3.55M -4.75% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$309M -$81.7M -$2M -2.51% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-08
Q3 2020 -$307M -$74.7M -$2.15M -2.96% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$305M -$78M -$2.42M -3.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$302M -$74.7M -$6.81M -10% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$296M -$79.7M +$2.12M +2.59% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$298M -$72.6M -$12.3M -20.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$285M -$75.5M -$22.9M -43.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$263M -$67.9M -$25.4M -59.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$237M -$81.8M -$46M -129% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$191M -$60.2M -$28.6M -90.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$163M -$52.6M -$24.7M -88.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$138M -$42.5M -$16.3M -62.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$122M -$35.8M -$17M -90.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$104M -$31.7M -$5.72M -22% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$98.8M -$27.9M -$8.42M -43.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$90.3M -$26.2M -$9.1M -53.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$81.2M -$18.8M +$3.02M +13.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 -$84.3M -$25.9M -$13.7M -112% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$70.6M -$19.5M -$4.38M -29% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$66.2M -$17.1M -$7.75M -83.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$58.4M -$21.8M -$11.2M -105% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$47.3M -$12.3M -$6.31M -106% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$41M -$15.1M -$10.6M -233% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$30.4M -$9.31M -$2.23M -31.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$28.2M -$10.6M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 -$5.95M -$3.4M -133% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$4.53M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$7.08M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 -$2.55M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q4 2012 -$4.09M Aug 22, 2012 Dec 31, 2012 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.